Table 5.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1995 to 2004

Recipients with Kidney Transplants

  Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Functioning Graft at Discharge 10,590 10,888 11,240 11,990 12,268 13,098 13,811 14,322 14,677 15,536
With Immunosuppression Info 10,363 10,685 11,194 11,924 12,083 12,875 13,775 14,258 14,601 15,225
Corticosteroids Any in Category 93.3% 97.1% 97.4% 96.6% 97.3% 95.6% 93.5% 91.1% 84.7% 77.5%
Steroids 93.3% 97.1% 97.4% 96.6% 97.3% 95.6% 93.5% 91.1% 84.7% 77.5%
Cyclosporine Any in Category 81.7% 75.8% 76.5% 67.7% 61.5% 51.1% 37.5% 29.8% 25.9% 21.1%
Cyclosporin 73.6% 8.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1%
Sandimmmune 4.4% 11.6% 7.4% 5.4% 5.3% 3.1% 2.5% 1.4% 0.9% 0.6%
Neoral 3.7% 55.8% 69.1% 62.2% 55.9% 47.1% 30.2% 21.7% 19.2% 14.5%
Gengraf 0.0% 0.0% 0.0% 0.0% 0.2% 0.9% 4.7% 6.5% 5.7% 5.8%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.2% 0.1% 0.1%
Tacrolimus Any in Category 6.7% 12.5% 18.7% 26.4% 32.9% 44.1% 56.3% 63.8% 66.7% 72.1%
Tacrolimus 6.7% 12.5% 18.7% 26.4% 32.9% 44.1% 56.3% 63.8% 66.7% 72.1%
Antimetabolites Any in Category 77.4% 80.5% 86.4% 85.1% 86.3% 80.3% 79.7% 82.1% 82.8% 83.9%
Mycophenolate Mofetil 12.8% 48.5% 66.3% 72.9% 78.2% 74.8% 75.5% 79.2% 80.4% 81.0%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.4% 0.5% 1.6%
Azathioprine 64.6% 31.8% 20.0% 12.1% 7.9% 5.3% 4.1% 2.3% 1.8% 1.3%
Leflunomide 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cytoxan 0.0% 0.2% 0.2% 0.1% 0.2% 0.2% 0.1% 0.1% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.1% 1.5% 3.4% 3.2% 3.0% 13.1% 17.3% 15.5% 15.7% 12.4%
Sirolimus 0.1% 1.5% 3.4% 3.0% 2.5% 13.0% 17.2% 14.9% 15.7% 12.2%
Everolimus 0.0% 0.0% 0.0% 0.2% 0.4% 0.2% 0.1% 0.6% 0.0% 0.2%


Source: OPTN/SRTR Data as of May 2, 2005.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients maybe prescribed more than one drug within the same category.